Drugs Are Expensive Because Of The “Westin Effect,” Tunis Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Health care system is not price sensitive because many actors are on “expense accounts,” former CMS chief medical officer says.
You may also be interested in...
CMS' Tunis Accepts Suspended License, Fine To Resolve Medical Board Charges
The agency's chief medical officer agrees to a $20,000 fine and accepts a one-year suspension of his physician's license to resolve charges that he falsified continuing medical education documents. Tunis has been on indefinite administrative leave from CMS since April.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.